172 related articles for article (PubMed ID: 34358083)
21. Design, Synthesis, and Pharmacological Characterization of 2-(2-Furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine Derivatives: New Highly Potent A
Varano F; Catarzi D; Vincenzi F; Betti M; Falsini M; Ravani A; Borea PA; Colotta V; Varani K
J Med Chem; 2016 Dec; 59(23):10564-10576. PubMed ID: 27933962
[TBL] [Abstract][Full Text] [Related]
22. The Influence of the 1-(3-Trifluoromethyl-Benzyl)-1H-Pyrazole-4-yl Moiety on the Adenosine Receptors Affinity Profile of Pyrazolo[4,3-e][1,2,4]Triazolo[1,5-c]Pyrimidine Derivatives.
Federico S; Redenti S; Sturlese M; Ciancetta A; Kachler S; Klotz KN; Cacciari B; Moro S; Spalluto G
PLoS One; 2015; 10(12):e0143504. PubMed ID: 26625265
[TBL] [Abstract][Full Text] [Related]
23. Chalcone-based derivatives as new scaffolds for hA3 adenosine receptor antagonists.
Vazquez-Rodriguez S; Matos MJ; Santana L; Uriarte E; Borges F; Kachler S; Klotz KN
J Pharm Pharmacol; 2013 May; 65(5):697-703. PubMed ID: 23600387
[TBL] [Abstract][Full Text] [Related]
24. 1,2,4-triazolo[1,5-a]quinoxaline derivatives and their simplified analogues as adenosine A₃ receptor antagonists. Synthesis, structure-affinity relationships and molecular modeling studies.
Catarzi D; Varano F; Poli D; Squarcialupi L; Betti M; Trincavelli L; Martini C; Dal Ben D; Thomas A; Volpini R; Colotta V
Bioorg Med Chem; 2015 Jan; 23(1):9-21. PubMed ID: 25497490
[TBL] [Abstract][Full Text] [Related]
25. Chiral pyrrolo[2,3-d]pyrimidine and pyrimido[4,5-b]indole derivatives: structure-activity relationships of potent, highly stereoselective A1-adenosine receptor antagonists.
Müller CE; Geis U; Grahner B; Lanzner W; Eger K
J Med Chem; 1996 Jun; 39(13):2482-91. PubMed ID: 8691445
[TBL] [Abstract][Full Text] [Related]
26. 4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives.
Catarzi D; Varano F; Vigiani E; Calenda S; Melani F; Varani K; Vincenzi F; Pasquini S; Mennini N; Nerli G; Dal Ben D; Volpini R; Colotta V
Pharmaceuticals (Basel); 2022 Apr; 15(4):. PubMed ID: 35455475
[TBL] [Abstract][Full Text] [Related]
27. Development of novel adenosine receptor ligands based on the 3-amidocoumarin scaffold.
Matos MJ; Vilar S; Kachler S; Celeiro M; Vazquez-Rodriguez S; Santana L; Uriarte E; Hripcsak G; Borges F; Klotz KN
Bioorg Chem; 2015 Aug; 61():1-6. PubMed ID: 26042529
[TBL] [Abstract][Full Text] [Related]
28. Molecular modeling of A1 and A2A adenosine receptors: comparison of rhodopsin- and beta2-adrenergic-based homology models through the docking studies.
Yuzlenko O; Kieć-Kononowicz K
J Comput Chem; 2009 Jan; 30(1):14-32. PubMed ID: 18496794
[TBL] [Abstract][Full Text] [Related]
29. Structural investigation on thiazolo[5,4-d]pyrimidines to obtain dual-acting blockers of CD73 and adenosine A
Varano F; Catarzi D; Vincenzi F; Pasquini S; Pelletier J; Lopes Rangel Fietto J; Espindola Gelsleichter N; Sarlandie M; Guilbaud A; Sévigny J; Varani K; Colotta V
Bioorg Med Chem Lett; 2020 May; 30(9):127067. PubMed ID: 32165041
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and structure-activity relationship of pyrazolo[3,4-d]pyrimidines: potent and selective adenosine A1 receptor antagonists.
Poulsen SA; Quinn RJ
J Med Chem; 1996 Oct; 39(21):4156-61. PubMed ID: 8863792
[TBL] [Abstract][Full Text] [Related]
31. New 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives. Evaluation of different moieties on the 6-aryl ring to obtain potent and selective human A
Falsini M; Ceni C; Catarzi D; Varano F; Dal Ben D; Marucci G; Buccioni M; Martí Navia A; Volpini R; Colotta V
Bioorg Med Chem Lett; 2020 Jun; 30(11):127126. PubMed ID: 32241719
[TBL] [Abstract][Full Text] [Related]
32. 5,7-Disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazines as pharmacological tools to explore the antagonist selectivity profiles toward adenosine receptors.
Federico S; Ciancetta A; Porta N; Redenti S; Pastorin G; Cacciari B; Klotz KN; Moro S; Spalluto G
Eur J Med Chem; 2016 Jan; 108():529-541. PubMed ID: 26717203
[TBL] [Abstract][Full Text] [Related]
33. Coumarins and adenosine receptors: New perceptions in structure-affinity relationships.
Fonseca A; Matos MJ; Vilar S; Kachler S; Klotz KN; Uriarte E; Borges F
Chem Biol Drug Des; 2018 Jan; 91(1):245-256. PubMed ID: 28734062
[TBL] [Abstract][Full Text] [Related]
34. Probing Substituents in the 1- and 3-Position: Tetrahydropyrazino-Annelated Water-Soluble Xanthine Derivatives as Multi-Target Drugs With Potent Adenosine Receptor Antagonistic Activity.
Koch P; Brunschweiger A; Namasivayam V; Ullrich S; Maruca A; Lazzaretto B; Küppers P; Hinz S; Hockemeyer J; Wiese M; Heer J; Alcaro S; Kiec-Kononowicz K; Müller CE
Front Chem; 2018; 6():206. PubMed ID: 29998095
[TBL] [Abstract][Full Text] [Related]
35. N9-benzyl-substituted 1,3-dimethyl- and 1,3-dipropyl-pyrimido[2,1-f]purinediones: synthesis and structure-activity relationships at adenosine A1 and A2A receptors.
Drabczyńska A; Müller CE; Karolak-Wojciechowska J; Schumacher B; Schiedel A; Yuzlenko O; Kieć-Kononowicz K
Bioorg Med Chem; 2007 Jul; 15(14):5003-17. PubMed ID: 17499511
[TBL] [Abstract][Full Text] [Related]
36. Discovery of first-in-class multi-target adenosine A
Ceni C; Catarzi D; Varano F; Ben DD; Marucci G; Buccioni M; Volpini R; Angeli A; Nocentini A; Gratteri P; Supuran CT; Colotta V
Eur J Med Chem; 2020 Sep; 201():112478. PubMed ID: 32659606
[TBL] [Abstract][Full Text] [Related]
37. Substituted 4-phenylthiazoles: Development of potent and selective A
Abdelrahman A; Yerande SG; Namasivayam V; Klapschinski TA; Alnouri MW; El-Tayeb A; Müller CE
Eur J Med Chem; 2020 Jan; 186():111879. PubMed ID: 31780082
[TBL] [Abstract][Full Text] [Related]
38. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives: potent and selective A(2A) adenosine antagonists.
Baraldi PG; Cacciari B; Spalluto G; Pineda de las Infantas y Villatoro MJ; Zocchi C; Dionisotti S; Ongini E
J Med Chem; 1996 Mar; 39(5):1164-71. PubMed ID: 8676354
[TBL] [Abstract][Full Text] [Related]
39. Creatine, similarly to ketamine, affords antidepressant-like effects in the tail suspension test via adenosine A₁ and A2A receptor activation.
Cunha MP; Pazini FL; Rosa JM; Ramos-Hryb AB; Oliveira Á; Kaster MP; Rodrigues AL
Purinergic Signal; 2015 Jun; 11(2):215-27. PubMed ID: 25702084
[TBL] [Abstract][Full Text] [Related]
40. Structural refinement of pyrazolo[4,3-d]pyrimidine derivatives to obtain highly potent and selective antagonists for the human A3 adenosine receptor.
Squarcialupi L; Catarzi D; Varano F; Betti M; Falsini M; Vincenzi F; Ravani A; Ciancetta A; Varani K; Moro S; Colotta V
Eur J Med Chem; 2016 Jan; 108():117-133. PubMed ID: 26638043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
